Notable Analyst Rating Changes 02/26: RST, AZN/GSK, CHA/CHU, OSIS, LAMR Upgraded; PALM, DPS, ATHN, FLR, MOT Downgraded
Tweet Send to a Friend
UPGRADES
Jefferies & Co upgrades Rosetta Stone (NYSE: RST) from Hold to Buy. Price target raised from $24 to $29.
Goldman Sachs ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies & Co upgrades Rosetta Stone (NYSE: RST) from Hold to Buy. Price target raised from $24 to $29.
Goldman Sachs ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
